Novel Biomarkers for the Diagnosis and Subtyping of Small B-Cell Lymphomas
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2023/04/N2CR-Seminar-02-600-×-450-px-10.png)
The accurate diagnosis of the most common small B-cell lymphoma histological subtypes can pose a significant challenge for pathologists. There is an urgent need to address this challenge as the […]
Novel Treatment Strategy for Gastric Cancer
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2023/04/N2CR-Seminar-02-600-×-450-px-9.png)
Gastric cancer with the development of peritoneal metastasis (cancer that has spread to the peritoneum) can be an incapacitating disease with poor survival outcome. This disease is usually treated with […]
Improving Patient Selection for Phase I Clinical Trials
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2023/04/website-homepage-banners-13-1024x576.png)
Phase I trials are an essential part of bringing new cancer therapies into the clinic. As participation in Phase I trials usually requires life expectancy of greater than 3 months […]
Immunotherapy for Advanced Oesophageal Squamous Cell Carcinoma
![](https://medicine.nus.edu.sg/trp/n2cr/wp-content/uploads/sites/8/2023/04/website-homepage-banners-12-1024x576.png)
Immune checkpoint inhibitors (ICIs), a type of therapy which can greatly enhance the ability of the immune system to recognise and attack cancer cells, have been effective in improving the […]